PTCT logo

PTC Therapeutics (PTCT)

Profile

Full Name

PTC Therapeutics, Inc.

Ticker Symbol

PTCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 20, 2013

Indexes

Not included

Website

http://www.ptcbio.com

Employees

939

Key Details

Price

$47.20(+0.51%)

Market cap

$3.74B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$806.78M(-13.97% YoY)

Annual EPS

-$4.73(+43.49% YoY)

PE ratio

7.25

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $47.20
    PTCT price is $47.20

    30-Day Relative Volume

    0.43
    PTCT 30-day relative volume is 0.43

    Price Performance

    Price Most recent change

    +0.51%
    PTCT price was up +0.51% on May 20, 2025

    Price YTD change

    +4.56%
    PTCT price is up +4.56% since January 1st

    Price 1-year change

    +17.65%
    PTCT price is up +17.65% year-on-year

    Price 3-year change

    +45.99%
    PTCT price is up +45.99% over the past 3 years

    Price Range

    Price All-time high

    $78.72
    PTCT price is currently -40.04% below its historical high of $78.72

    Price 3-year low

    $17.53
    PTCT price is currently +169.25% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.74B
    PTCT market capitalization is $3.74 billion

    Market cap 3-year change

    +62.2%
    PTCT market capitalization is up +62.2% over the past 3 years

    Market cap All-time high

    $4.80B
    PTCT market capitalization is currently -22.14% below its historical high of $4.80 billion

    Market cap sector rank

    87.31%
    PTCT market capitalization is higher than 87.31% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.34%
    PTCT shares outstanding is up +3.34% year-on-year

    Shares Outstanding 3-Year Change

    +11.1%
    PTCT shares outstanding is up +11.1% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.06
    PTCT beta is 1.06

    200-day SMA

    $43.63
    PTCT price is currently +8.18% above its 200-day simple moving average

    50-day SMA

    $48.56
    PTCT price is currently -2.80% below its 50-day simple moving average

    RSI

    52.03
    PTCT 14-day relative strength index is 52.03

    Volume

    0.43
    PTCT 30-day relative volume is 0.43

    ATR

    $2.53
    PTCT average true range is $2.53

    10-day Historical Volatility

    65.20%
    PTCT 10-day historical volatility is 65.20%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $806.78M
    PTCT annual revenue is $806.78 million

    Revenue Analysts estimate

    $1.50B
    PTCT annual revenue is currently -46.08% lower than the consensus analysts' forecast

    Revenue 1-year change

    -13.97%
    PTCT annual revenue is down -13.97% year-on-year

    Revenue Sector rank

    79.07%
    PTCT annual revenue is higher than 79.07% of companies in Healthcare sector

    EPS

    EPS

    -$4.73
    PTCT annual earnings per share is -$4.73

    EPS Analysts estimate

    $7.86
    PTCT annual earnings per share is currently -160.20% lower than the consensus analysts' forecast

    EPS 1-year change

    +43.49%
    PTCT annual earnings per share is up +43.49% year-on-year

    EPS Sector rank

    20.02%
    PTCT annual earnings per share is higher than 20.02% of companies in Healthcare sector

    Profit

    Gross profit

    $749.38M
    PTCT annual gross profit is $749.38 million

    Gross margin

    92.89%
    PTCT annual gross profit margin is 92.89%

    Operating profit

    -$146.75M
    PTCT annual operating income is -$146.75 million

    Operating margin

    -18.19%
    PTCT annual operating profit margin is -18.19%

    Net income

    -$363.30M
    PTCT annual net profit is -$363.30 million

    Net margin

    -45.03%
    PTCT annual net profit margin is -45.03%

    Expenses

    Total expenses

    $953.53M
    PTCT annual total expenses is $953.53 million

    Operating expenses

    $896.13M
    PTCT annual total operating expenses is $896.13 million

    Cost of goods sold

    $57.40M
    PTCT annual cost of goods sold is $57.40 million

    Selling, general & administrative expenses

    $300.91M
    PTCT annual SGA is $300.91 million

    Depreciation and amortization

    $75.66M
    PTCT annual depreciation & amortization is $75.66 million

    Interest expense

    $166.99M
    PTCT annual interest expense is $166.99 million

    Income tax

    $176.00K
    PTCT annual income tax is $176.00 thousand

    EBIT & EBITDA

    EBIT

    -$196.13M
    PTCT annual earnings before interest & taxes is -$196.13 million

    EBITDA

    -$120.46M
    PTCT annual EBITDA is -$120.46 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.71B
    PTCT annual total assets is $1.71 billion

    Non current assets

    $339.49M
    PTCT annual long term assets is $339.49 million

    Current assets

    $1.37B
    PTCT annual total current assets is $1.37 billion

    Cash and cash equivalents

    $779.71M
    PTCT annual cash & cash equivalents is $779.71 million

    Accounts receivable

    $158.55M
    PTCT annual accounts receivable is $158.55 million

    Inventory

    $23.19M
    PTCT annual inventory is $23.19 million

    Liabilities

    Total liabilities

    $2.80B
    PTCT annual total liabilities is $2.80 billion

    Long term liabilities

    $2.22B
    PTCT annual total long term liabilities is $2.22 billion

    Current liabilities

    $580.98M
    PTCT annual total current liabilities is $580.98 million

    Accounts payable

    $17.27M
    PTCT annual accounts payable is $17.27 million

    Debt

    Total debt

    $2.47B
    PTCT annual total debt is $2.47 billion

    Total debt 1-year change

    +10.85%
    PTCT annual total debt is up +10.85% year-on-year

    Long term debt

    $2.20B
    PTCT annual long term debt is $2.20 billion

    Short term debt

    $271.18M
    PTCT annual short term debt is $271.18 million

    Equity & Capital

    Shareholders equity

    -$1.10B
    PTCT annual stockholders equity is -$1.10 billion

    Book value

    -$1.10B
    PTCT annual book value is -$1.10 billion

    Retained earnings

    -$3.65B
    PTCT annual retained earnings is -$3.65 billion

    Working capital

    $784.55M
    PTCT annual working capital is $784.55 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$107.69M
    PTCT annual cash flow from operations is -$107.69 million

    Cash from operations 1-year change

    +32.02%
    PTCT annual cash flow from operations is up +32.02% year-on-year

    Cash from investing

    $44.18M
    PTCT annual cash flow from investing activities is $44.18 million

    Cash from investing 1-year change

    +125%
    PTCT annual cash flow from investing activities is up +125% year-on-year

    Cash from financing

    $255.87M
    PTCT annual cash flow from financing activities is $255.87 million

    Cash from financing 1-year change

    -60.42%
    PTCT annual cash flow from financing activities is down -60.42% year-on-year

    CAPEX

    CAPEX

    $74.25M
    PTCT annual capital expenditures is $74.25 million

    CAPEX 1-year change

    -38.44%
    PTCT annual capital expenditures is down -38.44% year-on-year

    Free Cash Flow

    Free cash flow

    -$181.94M
    PTCT annual free cash flow is -$181.94 million

    Free cash flow 1-year change

    +34.8%
    PTCT annual free cash flow is up +34.8% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    92.89%
    PTCT annual gross profit margin is 92.89%

    Operating margin

    -18.19%
    PTCT annual operating profit margin is -18.19%

    Net margin

    -45.03%
    PTCT annual net profit margin is -45.03%

    ROA & ROE

    ROA

    -20.18%
    PTCT annual return on assets is -20.18%

    ROE

    33.08%
    PTCT annual return on equity is 33.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    7.25
    PTCT price to earnings ratio is 7.25

    PE ratio Sector rank

    9.57%
    PTCT price to earnings ratio is higher than 9.57% of companies in Healthcare sector

    PB Ratio

    PB ratio

    -20.14
    PTCT price to book ratio is -20.14

    PB ratio Sector rank

    2.21%
    PTCT price to book ratio is higher than 2.21% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.11
    PTCT price to sales ratio is 2.11

    PS ratio Sector rank

    42.21%
    PTCT price to sales ratio is higher than 42.21% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $2.65B
    PTCT enterprise value is $2.65 billion

    Enterprise value Sector rank

    83.46%
    PTCT enterprise value is higher than 83.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    3.16
    PTCT EV/EBITDA is 3.16

    EV/EBITDA Sector rank

    76.2%
    PTCT EV/EBITDA is higher than 76.2% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.35
    PTCT annual current ratio is 2.35

    Quick ratio

    2.31
    PTCT annual quick ratio is 2.31

    Leverage

    Debt to equity

    -2.16
    PTCT annual debt to equity ratio is -2.16

    Interest coverage ratio

    -1.17
    PTCT annual interest coverage ratio is -1.17

    Risk & Stability

    Piotroski F-Score

    8
    PTCT piotroski f-score is 8

    Altman Z-Score

    -1.55
    PTCT altman z-score is -1.55

    Analyst ratings

    Recent major analysts updates

    May 9, 25 B of A Securities
    Buy
    May 8, 25 Barclays
    Equal-Weight
    May 7, 25 RBC Capital
    Outperform
    May 7, 25 JP Morgan
    Overweight
    May 7, 25 Citigroup
    Neutral
    May 7, 25 Cantor Fitzgerald
    Overweight
    May 7, 25 Baird
    Outperform
    Apr 22, 25 RBC Capital
    Outperform
    Mar 31, 25 JP Morgan
    Overweight
    Mar 14, 25 JP Morgan
    Overweight

    Institutional Ownership

    Screeners with PTCT included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for PTC Therapeutics?
    • Does PTC Therapeutics pay dividends?
    • What sector is PTC Therapeutics in?
    • What industry is PTC Therapeutics in?
    • What country is PTC Therapeutics based in?
    • When did PTC Therapeutics go public?
    • Is PTC Therapeutics in the S&P 500?
    • Is PTC Therapeutics in the NASDAQ 100?
    • Is PTC Therapeutics in the Dow Jones?
    • When was PTC Therapeutics's last earnings report?
    • When does PTC Therapeutics report earnings?
    • Should I buy PTC Therapeutics stock now?

    What is the ticker symbol for PTC Therapeutics?

    The ticker symbol for PTC Therapeutics is NASDAQ:PTCT

    Does PTC Therapeutics pay dividends?

    No, PTC Therapeutics does not pay dividends

    What sector is PTC Therapeutics in?

    PTC Therapeutics is in the Healthcare sector

    What industry is PTC Therapeutics in?

    PTC Therapeutics is in the Biotechnology industry

    What country is PTC Therapeutics based in?

    PTC Therapeutics is headquartered in United States

    When did PTC Therapeutics go public?

    PTC Therapeutics's initial public offering (IPO) was on June 20, 2013

    Is PTC Therapeutics in the S&P 500?

    No, PTC Therapeutics is not included in the S&P 500 index

    Is PTC Therapeutics in the NASDAQ 100?

    No, PTC Therapeutics is not included in the NASDAQ 100 index

    Is PTC Therapeutics in the Dow Jones?

    No, PTC Therapeutics is not included in the Dow Jones index

    When was PTC Therapeutics's last earnings report?

    PTC Therapeutics's most recent earnings report was on May 6, 2025

    When does PTC Therapeutics report earnings?

    The next expected earnings date for PTC Therapeutics is Aug 8, 2025

    Should I buy PTC Therapeutics stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page